The YTS-1/NEU1-injected mice showed significantly slower tumor growth (Fig. 6d), and a much smaller total tumor mass (Fig. 6e, f), in comparison to YTS-1/Ctrl-injected mice. Here, NEU1 is linked to neoplasm.